Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
8.05
+0.01 (0.12%)
At close: Apr 1, 2025, 4:00 PM
8.15
+0.10 (1.28%)
After-hours: Apr 1, 2025, 7:56 PM EDT

Aurinia Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
1,1061,2861,2916142,9661,750
Upgrade
Market Cap Growth
-0.41%-0.41%110.30%-79.30%69.42%-20.79%
Upgrade
Enterprise Value
8271,0251,0472462,6881,367
Upgrade
Last Close Price
8.058.988.994.3222.8713.83
Upgrade
PE Ratio
201.25223.53----
Upgrade
Forward PE
17.3124.06----
Upgrade
PS Ratio
4.905.477.364.5865.0334.93
Upgrade
PB Ratio
3.003.413.421.516.194.29
Upgrade
P/TBV Ratio
3.453.453.461.546.304.39
Upgrade
P/FCF Ratio
25.0729.15----
Upgrade
P/OCF Ratio
24.9128.97----
Upgrade
EV/Sales Ratio
3.524.365.971.8458.9427.27
Upgrade
EV/EBITDA Ratio
25.8632.08----
Upgrade
EV/EBIT Ratio
66.0281.91----
Upgrade
EV/FCF Ratio
18.7423.25----
Upgrade
Debt / Equity Ratio
0.210.210.260.020.020.02
Upgrade
Debt / EBITDA Ratio
2.422.42----
Upgrade
Debt / FCF Ratio
1.801.80----
Upgrade
Asset Turnover
0.430.430.350.260.090.13
Upgrade
Inventory Turnover
1.241.241.982.303.14-
Upgrade
Quick Ratio
4.054.054.868.7611.8412.45
Upgrade
Current Ratio
4.574.575.509.6012.6313.11
Upgrade
Return on Equity (ROE)
1.52%1.52%-19.92%-24.46%-40.81%-29.07%
Upgrade
Return on Assets (ROA)
1.42%1.42%-10.53%-13.74%-22.43%-16.54%
Upgrade
Return on Capital (ROIC)
1.68%1.68%-12.06%-15.46%-24.99%-18.24%
Upgrade
Return on Capital Employed (ROCE)
2.80%2.80%----
Upgrade
Earnings Yield
0.52%0.45%-6.04%-17.62%-6.10%-5.87%
Upgrade
FCF Yield
3.99%3.43%-2.65%-13.00%-5.33%-4.32%
Upgrade
Buyback Yield / Dilution
-2.07%-2.07%-0.93%-9.70%-9.20%-27.36%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q